Cite

HARVARD Citation

    Revheim, M. et al. (2013). Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H. Acta oncologica. pp. 776-782. [Online]. 
  
Back to record